Trial Profile
An Open-label, Randomized, Single Period, Parallel-Cohort Study To Evaluate Serum and Pulmonary Pharmacokinetics Following Single and Multiple Dose Administration of Intravenous GSK2251052 in Healthy Adult Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Sep 2023
Price :
$35
*
At a glance
- Drugs Epetraborole (Primary)
- Indications Community-acquired pneumonia; Gram-negative infections
- Focus Pharmacokinetics
- Sponsors GSK
- 26 Jul 2011 Actual end date Mar 2011 added as reported by ClinicalTrials.gov.
- 26 Jul 2011 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 03 Jan 2011 New trial record